Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease

International Psychogeriatrics

Volumn 23, Issue 9, 2011, Pages 1386-1392

  Rasmuson, Sigbritt ^a   Näsman, Birgitta ^a   Olsson, Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adrenocorticotropin; Alzheimer's disease; androgens; cortisol; cytokines; diurnal rhythm

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; INTERLEUKIN 6; PRASTERONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; ALZHEIMER DISEASE; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ELDERLY CARE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MINI MENTAL STATE EXAMINATION; PHYSICAL EXAMINATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SEX DIFFERENCE;

ADRENOCORTICOTROPIC HORMONE; AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; MALE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053493128     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211000810     Document Type: Article

References (30)

1. Akiyama, H. et al. (2000). Inflammation and Alzheimer's disease. Neurobiology of Aging, 21, 383-421. doi: 10.1016/S0197-4580(00)00124-X.
2. Bornstein, S. R. and Chrousos, G. P. (1999). Clinical review 104: adrenocorticotropin (ACTH)-and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. Journal of Clinical Endocrinology and Metabolism, 84, 1729-1736. (Pubitemid 30644284)
3. Csernansky, J. G. et al. (2006). Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. American Journal of Psychiatry, 163, 2164-2169. doi: 10.1176/appi.ajp.163.12.2164. (Pubitemid 46114238)
4. Engelhart, M. J. et al. (2004). Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Archieves of Neurology, 61, 668-672. (Pubitemid 38637682)
5. Ferrari, E. et al. (2001). Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. European Journal of Endocrinology, 144, 319-329. (Pubitemid 32409583)
6. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198. doi: 10.1016/0022-3956(75)90026-6.
7. Hartmann, A., Veldhuis, J. D., Deuschle, M., Standhardt, H. and Heuser, I. (1997). Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiology of Aging, 18, 285-289. doi: 10.1016/S0197-4580(97)80309-0. (Pubitemid 27360064)
8. Hughes, C. P., Berg, L.,Danziger, W. L., Coben, L. A. and Martin, R. L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566-572. (Pubitemid 12124384)
9. Lupien, S. J. et al. (2005). Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology, 30, 225-242. doi: 10.1016/j.psyneuen.2004.08.003. (Pubitemid 39423357)
10. Mastorakos, G., Chrousos, G. P. and Weber, J. S. (1993). Recombinant interleukin-6 activates the hypothalamicpituitary-adrenal axis in humans. Journal of Clinical Endocrinology and Metabolism, 77, 1690-1694. doi: 10.1210/jc.77.6.1690. (Pubitemid 24000936)
11. McGeer, E. G. and McGeer, P. L. (2003). Inflammatory processes in Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27, 741-749. doi: 10.1016/S0278-5846(03)00124-6.
12. Montgomery, S. A. andÅsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389. (Pubitemid 9136500)
13. N̈asman, B. et al. (1991). Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biological Psychiatry, 30, 684-690.
14. N̈asman, B., Olsson, T., Viitanen, M. and Carlstr̈om, K. (1995). A subtle disturbance in the feedback regulation of the hypothalamic-pituitary- adrenal axis in the early phase of Alzheimer's disease. Psychoneuroendocrinology, 20, 211-220. doi: 10.1016/0306-4530(94)00054-E.
15. N̈asman, B., Olsson, T., Fagerlund, M., Eriksson, S., Viitanen, M. and Carlstr̈om, K. (1996). Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biological Psychiatry, 39, 311-318. doi: 10.1016/ 0006-3223(95)00173-5. (Pubitemid 26122557)
16. Naylor, J. C. et al. (2008). Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. Journal of Clinical Endocrinology and Metabolism, 93, 3173-3178. doi: 10.1210/jc.2007-1229.
17. Otte, C., Hart, S., Neylan, T. C., Marmar, C. R., Yaffe, K. and Mohr, D. C. (2005). A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology, 30, 80-91. doi: 10.1016/j.psyneuen.2004.06.002. (Pubitemid 39195047)
18. Pringle, A. K., Schmidt, W., Deans, J. K., Wulfert, E., Reymann, K. G. and Sundstrom, L. E. (2003). 7-Hydroxylated epiandrosterone (7-OH-EPIA) reduces ischaemia-induced neuronal damage both in vivo and in vitro. European Journal of Neuroscience, 18, 117-124. doi: 10.1046/j.1460-9568.2003.02734.x. (Pubitemid 36920852)
19. Rasmuson, S., N̈asman, B., Eriksson, S., Carlstr̈om, K. and Olsson, T. (1998). Adrenal responsivity in normal aging and mild to moderate Alzheimer's disease. Biological Psychiatry, 43, 401-407. doi: 10.1016/S0006-3223(97)00283-7. (Pubitemid 28172383)
20. Rasmuson, S., Andrew, R., N̈asman, B., Seckl, J. R., Walker, B. R. andOlsson, T. (2001). Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease. Biological Psychiatry, 49, 547-552. doi: 10.1016/S0006-3223(00)01015-5. (Pubitemid 32226413)
21. Rasmuson, S., N̈asman, B., Carlstr̈om, K. and Olsson, T. (2002). Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 13, 74-79. doi: 10.1159/000048637. (Pubitemid 34161151)
22. Rose, K. A. et al. (1997). Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alphahydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proceedings of the National Academy of Sciences of the United States of America, 94, 4925-4930. (Pubitemid 27214712)
23. Seckl, J. R. and Olsson, T. (1995). Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect? Journal of Endocrinology, 145, 201-211.
24. Sp̈ath-Schwalbe, E. et al. (1994). Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. Journal of Clinical Endocrinology and Metabolism, 79, 1212-1214. doi:10.1210/jc.79.4.1212. (Pubitemid 24342275)
25. Swanwick, G. R. et al. (1998). Hypothalamic-pituitaryadrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings. American Journal of Psychiatry, 155, 286-289. (Pubitemid 28074297)
26. Svec, F. and Lopez, A. (1989). Antiglucocorticoid actions of dehydroepiandrosterone and low concentrations in Alzheimer's disease. The Lancet, 2, 1335-1336. (Pubitemid 20005707)
27. Tan, Z. S. et al. (2007). Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology, 68, 1902-1908. doi: 10.1212/01.wnl.0000263217.36439.da. (Pubitemid 46848622)
28. Umegaki, H. et al. (2000). Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study. Brain Research, 881, 241-243. doi: 10.1016/S0006-8993(00)02847-X.
29. Yau, J. L. et al. (2003). Dehydroepiandrosterone 7-hydroxylase CYP7B: predominant expression in primate hippocampus and reduced expression in Alzheimer's disease. Neuroscience, 121, 307-314. doi: 10.1016/ S0306-4522(03)00438-X. (Pubitemid 37176919)
30. Yau, J. L., Noble, J., Graham, M. and Seckl, J. R. (2006). Central administration of a cytochrome P450-7B product 7 alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats. Journal of Neuroscience, 26, 11034-11040. doi: 10.1523/ JNEUROSCI.3189-06.2006. (Pubitemid 44772193)